Metformin, one of the most highly prescribed drugs for a variety of diseases, has been suggested to regulate and promote M2 macrophage polarization in obesity and atherosclerosis by activating M2 signaling pathways like AMPK and inhibiting NFκB activation pathways [54,55,56,57,58]. This evidence concerns the gene NFKB1 and atherosclerosis.